ETHK Labs (HKSE:01931) ROCE %: 3.13% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01931 ETHK Labs Inc HKSE:01931
74 GF Score
Price HK$0.59
GF Value HK$1.38
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is ETHK Labs ROCE %?

ETHK Labs HKSE:01931 74 ROCE % is 3.13% as of Dec. 2025. GuruFocus rates HKSE:01931 with a GF Score™ of 74/100 and a GF Value™ of HK$1.38 (Possible Value Trap). The stock has 9 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ETHK Labs's annualized ROCE % for the quarter that ended in Dec. 2025 was 3.13%.

ETHK Labs  (HKSE:01931) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

ETHK Labs ROCE % Related Terms

ETHK Labs ROCE % Historical Data

* Premium members only.

The historical data trend for ETHK Labs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ETHK Labs ROCE % Chart

ETHK Labs Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.12 9.12 10.26 11.44 4.18

ETHK Labs Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.66 10.56 12.86 4.95 3.13
HKSE:01931
74GF Score
ETHK Labs Inc HKSE:01931
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ETHK Labs ROCE % Calculation

ETHK Labs's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=164.515/( ( (5897.697 - 1651.335) + (6556.783 - 2931.409) )/ 2 )
=164.515/( (4246.362+3625.374)/ 2 )
=164.515/3935.868
=4.18 %

ETHK Labs's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=120.77/( ( (6732.299 - 2644.876) + (6556.783 - 2931.409) )/ 2 )
=120.77/( ( 4087.423 + 3625.374 )/ 2 )
=120.77/3856.3985
=3.13 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.13% mean?
ETHK Labs (HKSE:01931) has a ROCE % of 3.13% as of Dec. 2025.
Is ETHK Labs' ROCE % too high?
ETHK Labs' current ROCE % is 3.13%. The Medical Distribution industry median ROCE % is 9.01. ETHK Labs' value of 3.13% is 65.2% below this industry median. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' ROCE % compare to MCK and COR?
ETHK Labs' ROCE % of 3.13% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.01. ETHK Labs' value of 3.13% is 65.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.01, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ETHK Labs's current ROCE % of 3.13% is 65.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ETHK Labs's current ROCE % is 3.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.59 — trading 57.2% below its estimated fair value. The current ROCE % is 3.13% and 65.2% below the Medical Distribution industry median of 9.01. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current ROCE % is 3.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ETHK Labs (HKSE:01931) Overvalued in 2026?

Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued. The current stock price of HK$0.59 is trading 57.2% below its estimated GF Value™ of HK$1.38. GuruFocus considers ETHK Labs to be Possible Value Trap.

Key valuation signals for HKSE:01931:

  • ROCE %: 3.13%
  • GF Value™: HK$1.38 vs. price of HK$0.59 (57.2% below fair value)
  • GF Score™: 74/100 with 9 warning signs
  • Industry Position: 65.2% below the Medical Distribution median

No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ETHK Labs Business Description

Address Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score

Get the complete analysis for HKSE:01931

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.59
Price
HK$1.38
GF Value